Retour sur lavenir.net
   NYXOAH 1.412 € (-0,56 %)     SOFINA 228.000 € (+0,53 %)     CELYAD ONCOLOGY 0.247 € (-1,20 %)     ACKERMANS V.HAAREN 274.600 € (+2,16 %)     ARGENX SE 757.200 € (-0,53 %)     WDP 21.880 € (-0,18 %)     KINEPOLIS GROUP 37.750 € (+0,53 %)     AB INBEV 69.700 € (-0,06 %)     MELEXIS 74.350 € (0,00 %)     BARCO 8.490 € (+2,17 %)     GIMV 44.650 € (-0,33 %)     VGP 82.700 € (+0,73 %)     NYRSTAR 0.060 € (0,00 %)     AGEAS 71.050 € (-0,63 %)     BEKAERT 41.100 € (+0,98 %)     AZELIS GROUP 10.910 € (-0,55 %)     SOLVAY 26.460 € (-0,97 %)     SYENSQO 69.050 € (+1,54 %)     RECTICEL 11.800 € (+1,03 %)     UMICORE 20.180 € (-1,94 %)     EVS 26.700 € (-1,66 %)     ELIA GROUP 139.100 € (-0,50 %)     AEDIFICA 68.850 € (-0,43 %)     D'IETEREN GROUP 176.600 € (+4,13 %)     CMB.TECH 13.640 € (-1,73 %)     UCB 236.200 € (+1,59 %)     ONWARD MEDICAL 2.455 € (-1,01 %)     KBC ANCORA 85.900 € (+0,35 %)     ONTEX GROUP 2.220 € (+1,37 %)     KBC 121.950 € (+0,33 %)     MONTEA 67.200 € (-0,30 %)     TITAN S.A. 50.050 € (-0,40 %)     PROXIMUS 6.120 € (-0,16 %)     XIOR 27.700 € (+0,73 %)     IMMOBEL 21.700 € (+0,46 %)     BIOTALYS 3.000 € (-1,48 %)     ECONOCOM GROUP 1.480 € (0,00 %)     GBL 78.050 € (+0,19 %)     VASTNED 29.900 € (+0,50 %)     QRF 10.200 € (+0,99 %)     LOTUS BAKERIES 11 020.000 € (+0,73 %)     CARE PROPERTY INV. 12.720 € (+0,16 %)     HOME INVEST BE. 19.060 € (0,00 %)     SHURGARD 26.400 € (+0,57 %)     RETAIL ESTATES 68.400 € (-0,15 %)     DECEUNINCK 2.215 € (+0,91 %)     TUBIZE-FIN 204.800 € (+0,79 %)     IBA 16.640 € (-1,19 %)     FAGRON 23.900 € (0,00 %)     CAMPINE 217.000 € (-0,91 %)     BPOST 1.620 € (+0,62 %)     CENERGY 20.700 € (-1,71 %)     SIPEF 90.900 € (+1,22 %)     COLRUYT 37.860 € (+0,26 %)     WHAT'S COOKING GP 141.500 € (+0,35 %)     DEME GROUP 173.600 € (+1,28 %)     WAREHOUSES ESTATES 40.000 € (-0,25 %)     ORANGE BELGIUM 21.600 € (+0,47 %)     JENSEN-GROUP 84.600 € (+3,93 %)     CFE 12.350 € (-1,20 %)  
   FDJ UNITED 23.090 € (-0,47 %)     CIBOX INTER A CTIV 0.013 € (+1,63 %)     HAVAS 18.900 € (+2,44 %)     CVC CAPITAL 14.620 € (+6,40 %)     EXOSENS 55.900 € (-1,58 %)     OPMOBILITY 13.420 € (+2,05 %)     CEGEDIM 10.260 € (-0,77 %)     SOITEC 101.200 € (-1,51 %)     INVENTIVA 3.880 € (+1,57 %)     DASSAULT SYSTEMES 18.605 € (+1,17 %)     WENDEL 80.800 € (+0,62 %)     VALLOUREC 20.900 € (+0,24 %)     CARBIOS 5.900 € (+1,37 %)     STMICROELECTRONICS 60.430 € (-1,52 %)     BE SEMICONDUCTOR 246.700 € (-1,95 %)     SCHNEIDER ELECTRIC 273.550 € (+0,16 %)     VIRIDIEN 79.250 € (-1,18 %)     ASML HOLDING 1 560.000 € (+0,27 %)     LVMH 490.900 € (+1,65 %)     GALP ENERGIA-NOM 19.275 € (-0,75 %)     WORLDLINE 10.270 € (+7,89 %)     ARCADIS 35.300 € (+1,38 %)     ASM INTERNATIONAL 935.000 € (+0,80 %)     AXA 43.730 € (-1,31 %)     L'OREAL 376.450 € (-0,62 %)     DANONE 71.300 € (-0,59 %)     POSTNL 0.934 € (+0,59 %)     AIRBUS 194.440 € (-0,77 %)     PLUXEE 13.470 € (+4,58 %)     GENFIT 13.420 € (+3,23 %)     ADYEN 860.500 € (+3,99 %)     CHRISTIAN DIOR 454.800 € (+1,70 %)     MICHELIN 34.500 € (+0,94 %)     SAINT GOBAIN 76.760 € (+2,87 %)     VIVENDI SE 1.920 € (+0,21 %)     IMPRESA,SGPS 0.184 € (+1,32 %)     SHELL PLC 37.325 € (+1,25 %)     CELLECTIS 2.502 € (-1,50 %)     HERMES INTL 1 678.500 € (+2,07 %)     EDP 4.603 € (+0,85 %)     EDENRED 25.630 € (+3,01 %)     PERNOD RICARD 64.060 € (+0,91 %)     KERING 253.300 € (+3,71 %)     AIR FRANCE -KLM 12.990 € (+1,25 %)     CAPGEMINI 92.880 € (+3,04 %)     ENGIE 27.370 € (-0,15 %)     ABC ARBITRAGE 5.130 € (+1,38 %)     TF1 6.755 € (+0,22 %)     EDP RENEWABLES 14.180 € (+1,43 %)     FLOW TRADERS 26.120 € (+1,87 %)     PUBLICIS GROUPE SA 88.940 € (+2,30 %)     SOCIETE GENERALE 76.350 € (+1,42 %)     SARTORIUS STED BIO 189.300 € (+0,42 %)     FUGRO 9.630 € (+2,67 %)     UBISOFT ENTERTAIN 5.914 € (+8,28 %)     MEDIANTECHNOLOGIES 4.410 € (-1,56 %)     HEIJMANS KON 98.450 € (+2,39 %)     PROSUS 41.235 € (+5,22 %)     VALEO 12.725 € (+2,17 %)     NN GROUP 77.820 € (+0,44 %)  
News Réglementées
01/05/2023 14:01

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics Plc

The Vanguard Group, Inc. ( IRSH)
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics Plc

01-May-2023 / 13:01 GMT/BST


Ap27

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

  1.         Full name of discloser

The Vanguard Group, Inc.

  1.         Owner or controller of interests and short positions disclosed, if different from 1(a)

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

  1.         Name of offeror/offeree in relation to whose relevant securities this form relates

Use a separate form for each offeror/offeree

Horizon Therapeutics plc

  1.         If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

 

  1.         Date position held/dealing undertaken

For an opening position disclosure, state the latest practicable date prior to the disclosure

28 April 2023

  1.           In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

N/A

 

2. INTERESTS AND SHORT POSITIONS

 

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

 

Ap28

 

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

 

Class of relevant security
(Note 3)

US$0.0001 ordinary shares

 

Interests

Short positions

Number

%

Number

%

  1. Relevant securities owned and/or controlled

21,583,473

9.43%

 

 

  1. Cash-settled derivatives

 

 

 

 

  1. Stock-settled derivatives (including options) and agreements to purchase/ sell

 

 

 

 

Total

21,583,473

9.43%

 

 

 

All interests and all short positions should be disclosed.

 

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit
(Note 5)

US$0.0001 ordinary shares

Purchase

10,280

111.16 USD

US$0.0001 ordinary shares

Sale

7,673

111.16 USD

 

 

 

Ap29

 

(b) Cash-settled derivative transactions

 

Class of
relevant
security

Product
description
e.g. CFD

Nature of dealing
e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

Number of
reference
securities
(Note 6)

Price
per unit
(Note 5)

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of
relevant
security

Product
description e.g. call
option

Writing, purchasing, selling, varying
etc.

Number
of
securities
to which
option
relates
(Note 6)

Exercise
price per
unit

Type
e.g.
American,
European
etc.

Expiry
date

Option
money
paid/
received per unit

 

 

 

 

 

 

 

 

 

(ii) Exercise

 

Class of
relevant
security

Product
description
e.g. call
option

Exercising/
exercised
against

Number of
securities

Exercise
price per
unit
(Note 5)

  

 

 

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 3)

 

Class of
relevant
security

Nature of dealing
e.g. subscription,
conversion, exercise

Details

Price per unit (if
applicable)
(Note 5)

 Not Applicable

 

 

 

 

Ap30

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 none

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 none

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière